Regentis Biomaterials Ltd. (RGNT)

Price$3.20

Favorite Metrics

Price vs S&P 500 (4W)-13.76%

All Metrics

Price vs S&P 500 (YTD)-55.52%

10-Day Avg Trading Volume0.00M

3-Month Avg Trading Volume0.02M

52-Week High$8.35

13-Week Price Return-53.39%

3-Month Return Std Dev83.87%

Year-to-Date Return-54.01%

5-Day Price Return1.47%

Month-to-Date Return1.47%

Price vs S&P 500 (13W)-54.08%

52-Week Low$2.80

About

Regentis Biomaterials develops regenerative medicine solutions for orthopedic tissue repair. Its lead product, GelrinC, is a cell-free hydrogel implant designed to treat cartilage injuries in the knee, based on the company's proprietary Gelrin platform. The company targets the significant market opportunity in orthopedic regenerative medicine.